These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 12921577

  • 21. MWA combined with TACE as a combined therapy for unresectable large-sized hepotocellular carcinoma.
    Liu C, Liang P, Liu F, Wang Y, Li X, Han Z, Liu C.
    Int J Hyperthermia; 2011; 27(7):654-62. PubMed ID: 21966941
    [Abstract] [Full Text] [Related]

  • 22. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

  • 23. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M, Liver Cancer Study Group of Japan.
    AJR Am J Roentgenol; 2010 Mar 15; 194(3):830-7. PubMed ID: 20173167
    [Abstract] [Full Text] [Related]

  • 24. Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival.
    Kirchhoff TD, Bleck JS, Dettmer A, Chavan A, Rosenthal H, Merkesdal S, Frericks B, Zender L, Malek NP, Greten TF, Kubicka S, Manns MP, Galanski M.
    Hepatobiliary Pancreat Dis Int; 2007 Jun 15; 6(3):259-66. PubMed ID: 17548248
    [Abstract] [Full Text] [Related]

  • 25. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W, Li Y, He X, Chen Y.
    Hepatogastroenterology; 2003 Jun 15; 50(54):2079-83. PubMed ID: 14696468
    [Abstract] [Full Text] [Related]

  • 26. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
    Liu MZ, Wang XS, Cai L, Gu MF, Liu H, Li Q, Cui NJ, Zhang YQ, Li GH, Li JQ.
    Ai Zheng; 2005 Jan 15; 24(1):82-6. PubMed ID: 15642207
    [Abstract] [Full Text] [Related]

  • 27. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM, Kim JH, Park IS, Ko GY, Yoon HK, Sung KB, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.
    J Gastroenterol Hepatol; 2009 May 15; 24(5):806-14. PubMed ID: 19207681
    [Abstract] [Full Text] [Related]

  • 28. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY.
    Cancer; 1997 Jun 01; 79(11):2087-94. PubMed ID: 9179054
    [Abstract] [Full Text] [Related]

  • 29. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB.
    Aliment Pharmacol Ther; 2009 Jun 15; 29(12):1291-8. PubMed ID: 19392861
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH, Liu LM, Cheng WW, Meng ZQ, Lin JH, Chen Z, Zhang XJ, Jiang GL.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar 15; 28(3):222-6. PubMed ID: 16875612
    [Abstract] [Full Text] [Related]

  • 33. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH, Chen LH.
    Ai Zheng; 2004 Jul 15; 23(7):825-8. PubMed ID: 15248921
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
    Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, Imamura E, Park NJ, Shirai Y, Fujimoto K, Michida T, Hayashi N, Ikeda M.
    Semin Oncol; 1997 Apr 15; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
    [Abstract] [Full Text] [Related]

  • 35. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar 15; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Short and long term efficacy of high intensity focused ultrasound therapy for advanced hepatocellular carcinoma.
    Li YY, Sha WH, Zhou YJ, Nie YQ.
    J Gastroenterol Hepatol; 2007 Dec 15; 22(12):2148-54. PubMed ID: 18031373
    [Abstract] [Full Text] [Related]

  • 38. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients.
    Di Carlo V, Ferrari G, Castoldi R, De Nardi P, Bergamo C, Taccagni G, Salvioni M, Angeli E, Venturini M, Del Maschio A.
    Hepatogastroenterology; 1998 Dec 15; 45(24):1950-4. PubMed ID: 9951846
    [Abstract] [Full Text] [Related]

  • 39. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 15; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 40. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH.
    Taehan Kan Hakhoe Chi; 2002 Jun 15; 8(2):189-200. PubMed ID: 12499805
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.